Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer
Organ Preservation for Patients With Locally Advanced Rectal Adenocarcinoma: Evaluating the Efficacy of Short Course Radiation Therapy Followed by FOLFOX or CapeOX
Sponsor: Jonsson Comprehensive Cancer Center
A PHASE1 clinical study on Locally Advanced Rectal Carcinoma and Rectal Adenocarcinoma, this trial is actively recruiting participants. The trial is conducted by Jonsson Comprehensive Cancer Center and has accumulated 9 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
9 versions recorded-
Dec 2025 — Present [monthly]
Recruiting PHASE1
-
Mar 2025 — Dec 2025 [monthly]
Recruiting PHASE1
-
Sep 2024 — Mar 2025 [monthly]
Recruiting PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE1
-
Feb 2024 — Jul 2024 [monthly]
Recruiting PHASE1
▶ Show 4 earlier versions
-
Feb 2023 — Feb 2024 [monthly]
Recruiting PHASE1
-
Feb 2022 — Feb 2023 [monthly]
Recruiting PHASE1
-
Apr 2021 — Feb 2022 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
Feb 2021 — Apr 2021 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Jonsson Comprehensive Cancer Center
- Natera, Inc.
- The Joseph Drown Foundation
For direct contact, visit the study record on ClinicalTrials.gov .